Develops innovative non-opioid pain medicines for rapid, effective relief without addiction risk.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Latigo Bio is focused on developing innovative non-opioid pain medicines with best-in-class profiles. Their goal is to provide effective, rapid-acting pain relief by targeting pain at its source, without the risk of addiction.
Latigo Bio Funding
Sign up to gain insights into Latigo Bio funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series B | Jan 28, 2025 | 50M | ||
| Series A | Oct 04, 2023 | 65M | ||
| Series A | Sep 30, 2022 | 35M | ||
| Series A | Aug 25, 2020 | 33M | ||
| Series Seed | Dec 23, 2019 | 2M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Latigo Bio Management Team
Investors
5AM Ventures
Access Biotechnology
Qatar Investment Authority (QIA)
Cormorant Asset Management
Blue Owl Capital
Foresite Capital
Rock Springs Capital
Corner Ventures
Deep Track Capital
Kern Capital
Westlake Village BioPartners
Sanofi Ventures
UPMC Enterprises
Alexandria Venture Investments
Latigo Bio Valuations & Financials
View real-time NPM data on Latigo Bio stock including daily Latigo Bio stock price estimates, valuation history, and historical share price information. Access Latigo Bio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Latigo Bio pricing across six independent market signals. Looking for private company due diligence data sources on Latigo Bio? Get in touch to learn more.
Similar Companies
like Latigo Bio
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Droplet Biosciences
Healthcare & Life Sciences
Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Elligo Health Research
Healthcare & Life Sciences
Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.
FAQ
We have answers
Latigo Bio stock does not trade on public stock exchanges. Latigo Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Latigo Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Latigo Bio Stock does not trade on public stock exchanges. In order to sell Latigo Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Latigo Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Latigo Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Latigo Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Latigo Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Latigo Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Latigo Bio is a private company and has not had an IPO. There is currently no Latigo Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Latigo Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
